Oppenheimer Reiterates Outperform Rating on Jasper Therapeutics (JSPR)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| (NASDAQ: JSPR) | Delayed: 0.51 +0.01 (2.00%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.50 | 52 Week High | $ | |||
| Open | $0.50 | 52 Week Low | $ | |||
| Day High | $0.54 | P/E | N/A | |||
| Day Low | $0.48 | EPS | $ | |||
| Volume | 323,720 | |||||
